Chlamydia pneumoniae
Chlamydia pneumoniae has been studied in 3 papers since 2023: 2 observational studies in people; 1 in the past year. The newest paper, May 11, 2026: “Beyond association: A quantitative analysis of the infectious burden in Alzheimer's disease”.
3 papers study it1 findingUpdated
See all 3 papers on chlamydia pneumoniae
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“C. pneumoniae serology was associated with impaired performance on language testing”
Humans: a single group. Cells, worms or flies and mice: nothing yet.
- 1 lab in 1 country
- Funders: National Institute of Neurological Disorders and Stroke and 2 more
- Humans2
- In silico1
What did studies of chlamydia pneumoniae find?
1Studies of chlamydia pneumoniae measured one outcome, language performance.
Language performance
downin humans1
1 study
Language performance
downin humans1
Chlamydia pneumoniae is linked with worse language performance in humans (confounder-adjusted mixed linear regression).
“C. pneumoniae serology was associated with impaired performance on language testing”
Humansconfounder-adjusted mixed linear regression
Alzheimer's & dementia : the journal of the Alzheimer's Association
Latest
1 paper in 12 monthsJournal of Alzheimer's Disease
Beyond association: A quantitative analysis of the infectious burden in Alzheimer's disease
Computational studyAlzheimer's disease
Alzheimer's & Dementia
The association of common infectious exposures with cognitive performance in community-dwelling older adults
Cohort study of 593 peoplePopulations
Journal of the Neurological Sciences
Herpes simplex virus 2 serology is associated with thinner whole-brain cortex in community-dwelling older adults
Cross-sectional study of 455 peoplePopulations